There is a large variation in outcomes used in obstetric studies, many of which are criticized for using surrogate outcome without clinical relevance or combined outcome with disproportionately big weight of less relevant outcomes. A perinatal core outcome set is needed within the area of labour and delivery management at or near term to improve consistency of research, audit and comparison between caregivers.
Our planned study will include a systematic review of the literature and a two-round Delphi survey with patients, clinicians and researchers and other relevant Swedish stakeholders within the area, followed by a final consensus meeting. The aim of this study is to reach a robust consensus about a national perinatal core outcome set to be used in Sweden when studying and evaluating interventions and decision making within the area of labour and delivery at or near term, including timing of planned delivery, labour induction and augmentation, mode of delivery etc.
Planned collaborators include: Swedish Perinatal Working and Reference Group (Perinatal-ARG), Swedish neonatal society (Svensk Neonatalförening); Swedish Society of Obstetrics and Gynecology (SFOG), Swedish network for national clinical studies in Obstetrics and Gynecology (SNAKS); Swedish Association of Midwives (Barnmorskeförbundet), Swedish Pregnancy Register (Graviditetsregistret), (Swedish Medical Birth Register) MFR, obstetrician representatives from all Swedish labour and delivery wards, neonatologist representatives from all Swedish neonatal wards; patient representatives
Julia Savchenko, Sophia Brismar Wendel
Disease Category: Pregnancy & childbirth
Disease Name: N/A
Age Range: Unknown
Nature of Intervention: Other
- Clinical experts
- Patient/ support group representatives
- Policy makers
- COS for clinical trials or clinical research
- COS for practice
- Consensus meeting
- Delphi process
- Systematic review
Decision making within the area of labour and delivery (pregnant women)
Our planned study will include a systematic review of the literature and a two-round Delphi survey with patient representatives, clinicians and researchers and other relevant Swedish stakeholders within the area, followed by a final consensus meeting.